Updated COVID-19 vaccines are now available, offering improved protection against severe illness. These vaccines target XBB.1.5 and other Omicron subvariants. Residents in the United States aged 6 months or older are eligible to receive updated COVID-19 vaccines.
The primary objective of these updated vaccines is to mitigate the severity of COVID-19, particularly in those at greater risk of experiencing severe outcomes, including older individuals and those with underlying health conditions. The vaccines are anticipated to exhibit efficacy against current virus variants such as EG.5 and BA.2.86.